GMP+_B10_-_EN_9248

合集下载

欧盟GMP对注射用水纯水纯蒸汽系统的要求与验证

欧盟GMP对注射用水纯水纯蒸汽系统的要求与验证

系统出现热原反应
总结词
热原反应是注射用水纯水纯蒸汽系统中较为严重的问题,可能引发药品不良反应和热原污染,威胁患者的生命安 全。
详细描述
热原反应通常是由于水中细菌内毒素含量过高引起的。为避免热原反应,应严格控制水的灭菌温度和时间,确保 细菌内毒素含量符合标准。同时,应对系统进行定期的清洗和消毒,防止细菌滋生。在药品生产过程中,应对注 射用水进行严格的监控和检测,确保其质量和安全性。
总结词
微生物污染是注射用水纯水纯蒸汽系统中常见的质量问题,可能引发药品生产过 程中的交叉污染,影响药品的安全性和有效性。
详细描述
微生物污染可能来源于系统内部或外部环境。为避免微生物污染,需对系统进行 严格的清洁和消毒,并定期进行微生物检测。一旦发现微生物污染,应立即采取 措施进行控制和消除。
系统出现化学污染
系统的性能验证
水质检测
定期对注射用水进行水质检测,包括微生物 指标、化学指标和物理指标等,确保水质符 合规定要求。
蒸汽质量检测
对纯蒸汽系统输出的蒸汽进行质量检测,确保其干 燥度、温度和压力等指标达到标准。
系统效率评估
评估系统的产水能力和能源消耗,确保系统 在高效状态下运行,降低生产成本。
04
注射用水纯水纯蒸汽系统的常见 问题与解决方案
欧盟gmp对注射用水纯水纯 蒸汽系统的要求与验证
• 注射用水纯水纯蒸汽系统概述 • 欧盟gmp对注射用水纯水纯蒸汽系
统的要求 • 注射用水纯水纯蒸汽系统的验证方

• 注射用水纯水纯蒸汽系统的常见问 题与解决方案
• 注射用水纯水纯蒸汽系统的未来发 展趋势
01
注射用水纯水纯蒸汽系统概述
定义与特性
05
注射用水纯水纯蒸汽系统的未来 发展趋势

GMP认证制药用水与设备要求

GMP认证制药用水与设备要求

12
制药用水的水质标准
ห้องสมุดไป่ตู้
制药用水分类及水质标准
1)饮用水:应符合中华人民 共和国国家标准<生活饮用水卫生 标准》(GB5749-85) 2)纯化水:应符合<2010中 国药典》所收载的纯化水标准。 在制水工艺中通常采用在线检 测纯化水的电阻率值的大小,来反 映水中各种离子的浓度。制药行业 的纯化水的电阻率通常应 ≥0.5MΩ.CM/25℃,对于注射剂、滴 眼液容器冲洗用的纯化水的电阻率 应≥1MΩ.CM/25℃。 3)注射用水:应符合2005中国药典所收载的注射用水标准。
4
制药用水的输送
纯化水和制药用水宜采用易 拆卸清洗、消毒的不锈钢泵输送。 在需用压缩空气或氮气压送 的纯化水和注射用水的场合,压 缩空气和氮气须净化处理。 纯化水宜采用循环管路输送。 管路设计应简洁,应避免盲管和 死角。管路应采用不锈钢管或经 验证无毒、耐腐蚀、不渗出污染 离子的其他管材。 阀门宜采用无死角的卫生级 阀门,输送纯化水应标明流向。 输送纯化水和注射用水的管道、输送泵应定期清洗、消毒灭菌,验 证合格后方可投入使用。
13
Thank you!
11
制药用水分类
制药用水分类及水质标准
3)注射用水(Water for Injection):是以纯化水作为原水, 经特殊设计的蒸馏器蒸馏,冷凝冷 却后经膜过滤制备而得的水。注射 用水可作为配制注射剂用的溶剂。
4)灭菌注射用水(Sterile Water for Injection):为注射用水 依照注射剂生产工艺制备所得的水。 灭菌注射用水用于灭菌粉末的溶剂 或注射液的稀释剂。
6
药品GMP实施与认证P168 以及于药厂的要求
设备选材安装
第34条纯化水、注射用水的 制备、储存和分配应能防止微生 物的滋生和污染。储罐和输送管 道所用材料应无毒、耐腐蚀。 管道的设计和安装应避免死 角、盲管储罐和管道要规定清洗、 灭菌周期。 注射用水储罐的通气口应安 装不脱落纤维的疏水性除菌滤器。 注射用水的储存可采用80°C以 上保温、65°C以上保温循环或 4°C以下存放。 第35条用于生产和检验的仪器、仪表、量具、衡器等,其适用 范围和精密度应符合生产和检验要求,有明显的合格标志,并定期 校验。

欧盟GMP(中英文对照)

欧盟GMP(中英文对照)

欧盟GMP(中英⽂对照)(The words that are in the green background are new standards)(绿⾊背景下的内容为新标准)ANNEX 1MANUFACTURE OF STERILE MEDICINAL PRODUCTS附录1 ⽆菌医药产品的⽣产Principle总则The manufacture of sterile products is subject to special requirements in order to minimize risks of microbiological contamination, and of particulate and pyrogen contamination. Much depends on the skill, training and attitudes of the personnel involved. Quality Assurance is particularly important, and this type of manufacture must strictly follow carefully established and validated methods of preparation and procedure. Sole reliance for sterility or other quality aspects must not be placed on any terminal process or finished product test.⽆菌药品的⽣产,必须符合⼀些特殊的要求,以防⽌微⽣物、微粒和热源的污染。

这很⼤程度上依赖与⼯作⼈员的技术⽔平、培训和⼯作态度。

在这⽅⾯质量保证显得特别重要,这种类型的⽣产,必须严格按照完善的和经过验证的⽣产⽅法和⼯作程序。

保健食品GMP质量体系压缩空气系统再验证方案

保健食品GMP质量体系压缩空气系统再验证方案

保健食品GMP质量体系压缩空气系统再验证方案随着保健食品市场的不断发展壮大,对于保健食品的质量体系要求也越来越高。

GMP(Good Manufacturing Practice)即良好生产规范,是一套用于保障食品生产质量和安全的国际通用标准。

为了确保保健食品GMP 质量体系的有效性,压缩空气系统是需要进行再验证的。

一、再验证的目的与意义:1.确保压缩空气系统的运行和性能符合相关的GMP要求。

2.评估压缩空气系统的稳定性和可靠性,防止潜在的质量问题。

3.进一步完善压缩空气系统的操作规程和管理流程,提高生产过程的效率和质量。

二、再验证的步骤:1.再验证计划的编制:再验证计划应包含再验证的目的、范围、方法和持续时间等内容。

根据国际通用的GMP标准和相关法规,制定再验证计划。

2.再验证方案的编制:再验证方案应包括再验证的具体内容和要求,如压缩空气系统的运行参数、监测设备和方法、样品采集和检测标准等。

同时,明确再验证的时间节点和操作流程。

3.系统评估:对压缩空气系统的运行状况进行评估,包括设备的清洁度、安全性、操作程序的完备性、设备的有效维护和计划检查等。

4.设备验证:对压缩空气系统的设备进行验证,包括设备的安全性、稳定性、灭菌效果、气体质量等。

可以通过实验室测试、检查设备和相关文件等方式进行验证,并对验证结果进行统计分析。

5.操作规程验证:验证操作规程的有效性和严格执行情况,如设备的操作步骤、记录的填写完整性等。

可以通过抽查记录、访谈员工等方式进行验证。

6.再验证结果分析:根据再验证的结果和评估,分析压缩空气系统是否能够满足相关GMP要求。

对于不符合要求的地方,采取相应的纠正和预防措施。

7.再验证报告编制:根据再验证的结果和分析,编制再验证报告。

报告应详细记录再验证的内容、结果和结论,以及改进措施和计划。

三、再验证的周期:再验证的周期根据具体情况而定,一般建议每2-3年进行一次再验证。

在再验证之间,应进行日常的监测和维护,确保压缩空气系统的稳定性和可靠性。

GMP铝管灌装封尾机确认验证方案

GMP铝管灌装封尾机确认验证方案

GMP铝管灌装封尾机确认验证方案GMP( Good Manufacturing Practice)是指制药生产中的良好生产规范,旨在确保药品的质量、安全性和有效性。

GMP铝管灌装封尾机是一种用于灌装和封尾铝管的设备,必须符合GMP要求。

为了确保设备符合GMP标准,需要进行确认验证。

以下是GMP铝管灌装封尾机确认验证方案的详细描述。

1.验证目标及范围验证目标是确认GMP铝管灌装封尾机的设计和操作是否符合GMP要求,并确保其能够生产高质量、安全性和有效性的产品。

验证范围包括设备的设计、装置、工艺参数、操作程序和设备维护等。

2.验证方案(1)验证计划:制定验证计划,明确验证的时间表、验证方法和参与人员。

(2)设备设计确认:评估GMP铝管灌装封尾机的设计文件,包括技术规范书、维护手册和操作手册等,确保其符合GMP要求。

(3)设备安装确认:验证设备的安装是否符合GMP要求,包括设备位置、设备接地、设备清洁等。

(4)设备操作确认:验证设备操作是否符合GMP要求,包括校准和部件更换程序、清洗和消毒程序、操作程序和记录等。

(5)工艺参数验证:验证设备的工艺参数是否符合GMP要求,包括灌装量、灌装速度、封尾质量等。

(6)设备维护确认:验证设备的维护程序是否符合GMP要求,包括定期保养、设备维修和维护记录等。

3.验证方法(2)静态测试:对设备的设计和安装进行静态测试,包括检查设备的位置、接地、固定等。

(3)动态测试:对设备进行正常操作和故障操作测试,验证设备的操作是否符合GMP要求。

(4)在线监测:采集设备运行过程中的数据,并对工艺参数进行在线监测,确保其符合GMP要求。

(5)打样验证:对设备进行打样测试,生产一定数量的产品并进行质量检测,确保产品质量符合GMP要求。

4.验证记录每一步的验证结果都需要记录,包括验证计划、设备设计确认报告、设备安装确认报告、设备操作确认报告、工艺参数验证报告、设备维护确认报告等。

所有验证记录都需要包括验证日期、验证人员签名和结果等。

GMP铝塑泡罩包装机验证方案及报告

GMP铝塑泡罩包装机验证方案及报告

GMP铝塑泡罩包装机验证方案及报告
【摘要】
本文旨在讨论如何制定GMP铝塑泡罩包装机的验证方案和报告。

为此,首先介绍了GMP和铝塑泡罩包装机的概念,然后运用GMP的原则介绍了铝
塑泡罩包装机验证方案制定的步骤,最后介绍了铝塑泡罩包装机的验证报告。

【引言】
GMP(良好制造规范)全称为良好制造和发布实践,是指全球制药公
司在生产进程中所采用的标准。

采用GMP标准来控制和管理制造药品的质量,是确保全球药品质量安全的重要手段。

铝塑泡罩包装机是一种用于包装多种药品产品的设备,是成药灌装机
的一种。

它以铝塑薄膜为原料,通过模具热压成型,最终完成成型药品包
装的一种机械装置。

它可以有效地避免药品在包装、运输、存储过程中,
因外界环境条件导致污染,有效改善了药品的保质期。

GMP规定的铝塑泡罩包装机验证方案,应以确保其安全性和有效性为
前提,并结合设备的性能、技术和功能:
1.物料验证:在验证期间,铝塑泡罩包装机的物料应符合现行的
GMP规定,包括检验铝塑袋的外观、产品质量、热封质量及生产工艺要求。

2.机械验证:验证期间,应对铝塑泡罩包装机的机械部件进行全面
检查。

GMP实施指南—实验室控制系统

GMP实施指南—实验室控制系统

目录1 前言 (1)2 目的 (2)3 范围 (3)4 指南内容结构 (4)5.质量控制实验室总体描述 (5)5.1 职责 (5)5.2 布局 (5)5.2.1原则 (5)5.2.2 要求 (5)5.3 人员 (6)5.3.1 组织架构 (6)5.3.2 资质要求 (6)5.3.3 培训 (6)5.4 文件系统 (7)5.4.1 分类 (7)5.4.2 要求 (7)6 取样 (10)6.1 定义 (11)6.2 应用范围 (12)6.3 要求 (12)6.3.1人员 (12)6.3.2取样器具 (12)6.3.3样品容器 (13)6.3.4取样间 (13)6.4 流程实施 (13)6.4.1取样方案 (13)6.4.2取样 (14)6.4.3标识 (14)6.4.4取样记录 (14)6.4.5取样的异常处理 (14)6.4.6留样 (15)7 试剂及试液的管理 (17)7.1 定义和应用范围 (17)7.2 要求 (17)7.2.1 采购接收和标识 (17)7.2.2 储存和使用 (18)7.2.3 试剂使用效期的管理 (18)7.2.4 报废 (18)7.2.5 文件管理 (18)8 标准品/对照品 (19)8.1 定义 (19)8.2 分类 (19)8.3 应用范围 (20)8.4 要求 (20)8.4.1 接收 (20)8.4.2 标识 (20)8.4.3 标准溶液的稳定性研究 (20)i8.4.4 标准品、对照品的使用、处置和贮存 (21)8.4.5 文件管理 (21)9 实验室分析仪器的确认 (22)9.1 应用范围 (23)9.2 确认实施 (24)9.2.1 验证总计划 (24)9.2.2 确认方案 (24)9.2.3 确认实施 (25)9.2.4 确认报告 (27)9.2.5 系统适用性试验 (27)9.2.6 实验室仪器控制系统和数据处理系统的确认 (27)9.2.7 再确认 (28)10 实验室分析仪器的校准与维护 (32)10.1 定义 (33)10.2 应用范围 (33)10.3 要求 (33)10.3.1 人员 (33)10.3.2 分类 (34)10.3.3 实施指导 (34)10.3.4 文件 (36)11 分析方法的验证和确认 (45)11.1 分析方法 (46)11.2 方法验证 (46)11.3 方法确认 (47)11.4 适用范围 (47)11.5 方法验证的一般原则 (47)11.6 需要验证的检验项目 (47)11.7 方法验证内容 (49)11.7.1 准确度 (49)11.7.2 精密度 (50)11.7.3 专属性 (52)11.7.4 检测限(LOD) (53)11.7.5 定量限(LOQ) (53)11.7.6 线性 (54)11.7.7 范围 (55)11.7.8 耐用性 (55)11.8 方法确认 (59)11.9 方法再验证 (59)11.10 文件管理 (60)12 稳定性实验 (64)12.1 定义 (66)12.2 应用范围 (66)12.3 原则 (66)12.4 稳定性分类 (66)12.5 技术要点 (67)12.5.1 基本要求 (67)12.5.2 样品储存 (67)12.5.3 样品提取 (73)12.5.4 分析 (73)12.5.5 简化方案设计 (78)12.5.6 上市产品的稳定性试验 (79)ii12.5.7 评估 (80)12.5.8 数据汇总 (82)12.5.9 统计分析的程序 (82)12.6 文件 (83)12.6.1 标准操作规程 (83)12.6.2 稳定性实验草案 (83)12.6.3 计划 (83)12.6.4 记录 (83)12.6.5 报告 (84)12.6.6 年度趋势分析与评估 (84)12.7 稳定性超标或超趋势调查处理 (84)12.7.1 原则 (84)12.7.2 程序 (84)13 超出标准及超趋势的实验结果调查 (87)13.1 定义 (87)13.2 重要性 (87)13.3 应用范围 (87)13.4 实施 (87)13.4.1 一般原则 (87)13.4.2 流程 (88)13.4.3 文件 (93)13.7.2 职责的确定: (93)14 原始数据的管理 (98)14.1 实验室原始数据的范围 (99)14.1.1 实验室记录要求 (100)14.1.2 数据完整性 (100)14.1.3 数据记录形式 (100)14.2 实验室记录的设计 (101)14.3 实验室记录的填写和复核 (101)14.3.1 实验室记录的填写 (102)14.3.2 记录的复核 (102)14.3.3 记录更正要求 (103)14.4 记录的管理 (103)15 物料及产品的检验 (105)15.1 质量标准的管理 (108)15.1.1 质量标准的设计与制定 (109)15.1.2 质量标准的审核与批准 (110)15.1.3 质量标准的分发、撤销、复制、销毁 (110)15.2 检验 (111)15.2.1 检验样品: (111)15.3 检验报告书的管理 (111)15.4 委托检验 (112)15.4.1 原则 (115)15.4.2 应用范围 (115)16.4.3 职责 (116)16.4.4 受托方的选定 (116)15.4.5 合同签订 (117)15.4.6 合同实施 (117)15.4.7 结果评估 (117)15.4.8 实验后样品处理 (118)16 微生物检验 (119)iii16.1 应用范围 (120)16.2 原则 (120)16.3 人员资质及培训要求 (120)16.4 设施 (120)16.4.1 无菌及微生物限度检验等实验区域 (121)16.4.2 菌种处理、微生物鉴别和阳性对照室 (121)16.4.3 抗生素微生物检定室 (121)16.4.4 培养室及其他功能间 (121)16.5 设备 (122)16.5.1 无菌隔离器(如使用) (122)16.5.2 实验室用层流台 (123)16.5.3 培养箱 (123)16.5.4 蒸汽灭菌柜 (123)16.5.5 空调高效过滤器 (123)16.6 灭菌消毒方式 (123)16.7 菌种的管理 (124)16.8 培养基 (125)16.8.1 培养基的制备 (125)16.8.2 培养基的贮藏 (126)16.8.3 培养基的质量控制实验 (126)16.9 实验分类 (127)16.9.1 总菌落数检查 (127)16.9.2 控制菌检查 (132)16.9.3 非无菌产品的实验频率 (134)16.9.4 无菌检查法 (135)16.9.5 内毒素检查 (138)参考文献 (141)术语表 (142)关键词索引 (144)iv实验室控制系统GMP实施指南表格索引表格索引表1-1 指南逻辑关系图 (1)表9-1 自动取样溶出仪确认测试项目示例 (29)表10-1 仪器使用日志示例 (36)表10-2 校准记录示例 (37)表10-3 外部校准评估报告示例 (38)表10-4 分析天平校准要求示例 (40)表10-5 HPLC 校准项目及周期示例 (42)表10-6 HPLC年度预防性维护示例 (43)表11-1 检验项目和验证内容 (48)表11-2 方法验证对比表 (48)表11-3 准确度方法验证示例 (49)表11-4 精密度验证方法 (51)表11-5 中间精密度的设计方案 (51)表11-5 专属性方法验证 (52)表11-6 杂质测定检测限验证方法 (53)表11-7 杂质定量测定验证方法 (53)表11-8 线性验证和准确度验证需涵盖的最低浓度范围 (54)表11-9 方法耐用性影响因素示例 (55)表11-10 HPLC含量方法耐用性考虑因素及变化范围示例 (56)表11-11 分析方法验证接受标准示例 (56)表12-1 四个气候带的分类表 (67)表12-2 标准贮藏条件表 (68)表12-3 温度选择性制剂的标准贮藏条件 (69)表12-4 原料药包装分类(水蒸气渗透性) (69)表12-5 原料药及制剂影响因素试验条件 (71)表12-6 半渗透包装标准贮藏条件 (72)表12-7 密闭包装贮藏条件 (72)表12-8 拟冷藏药物的贮藏条件 (72)表12-9 拟冷冻贮藏药物标准贮藏条件 (72)表12-10 稳定性试验点时间表 (74)表12-11 原料药及制剂稳定性重点考察项目参考表 (74)表12-12 片剂中间产品放置时间研究示例 (77)表12-13 转运运输条件示例 (78)表12-14 括号法方案设计 (79)表12-15 矩阵法方案设计 (79)表16-1 非无菌制剂产品类型与检验频次示例 (134)表16-2 原料检验频次及分类标准示例 (135)v表格索引实验室控制系统GMP实施指南vi实验室控制系统GMP实施指南 1 前言1 前言作为质量管理体系的一部分,质量控制实验室管理是确保所生产的药品适用于预定的用途,符合药品标准和规定的要求的重要因素之一。

GMP认证常用仪器分类整理

GMP认证常用仪器分类整理

GMP是一套适用于制药、食品等行业的强制性标准,要求企业从原料、人员、设施设备、生产过程、包装运输、质量控制等方面按国家有关法规达到卫生质量要求,形成一套可操作的作业规范帮助企业改善企业卫生环境,及时发现生产过程中存在的问题,加以改善。

简要的说,GMP要求制药、食品等生产企业应具备良好的生产设备,合理的生产过程,完善的质量管理和严格的检测系统,确保最终产品质量(包括食品安全卫生)符合法规要求。

国达仪器商城是GMP认证领域的合作企业。

下列仪器清单为GMP认证常用仪器设备。

色谱仪器:T◆E-L:4001158566高效液相色谱仪,色谱工作站,固相萃取仪,氮吹仪,示差检测器,蒸发光散射检测器,自动进样器,气相色谱仪,氮吹仪,热解析仪,顶空进样器,空气压缩机,氢气发生器,氮气发生器,三气一体机,氢火焰检测器,氮磷检测器,火焰光度检测器,电子捕获检测器,热导检测器,气体净化器光谱仪器:可见分光光度计,紫外可见分光光度计,双光束紫外可见分光光,原子吸收分光光度计,红外分光光度计,近红外分光光度计,荧光分光光度计,薄层色谱扫描仪,薄层点样器,薄层条带点样器,电动喷雾器,,薄层铺板机,薄层展开仪,火焰光度计,紫外线强度计,食品安全快速分析仪,总有机碳分析仪,微波消解仪,农药残毒速测仪洁净区检测设备净化工作台,生物安全柜,采样车,尘埃粒子计数器,浮游菌采样器,风量罩,照度计,风速仪,压差仪,声级计,菌落计数器,洁净双向传递窗,一氧化碳分析仪,甲醛测定仪,测氨仪,臭氧分析仪电化学仪器:酸度计,电导率仪,电位滴定仪,永停滴定仪,水分滴定仪—容量法,水分滴定仪—库仑法,水分滴定仪—干燥法,PH/溶解氧双参数测量仪,PH/电导率双参数测量仪,电导率/溶解氧双参数测量仪),BOD测定仪,多参数水质测量仪,COD测定仪,氨氮测定仪,溶解氧分析仪,化学耗氧量仪,离子计,多参数离子浓度检测仪,酸碱浓度计,水质硬度仪,亚硝酸盐氮检测仪,COD在线检测仪,氨氮在线检测仪,PH在线检测仪,电导率在线检测仪,多参数水在线检测仪,氯离子在线检测仪,溶解氧在线检测仪,重金属在线检测仪,自动滴定在线检测仪物性及物理光学仪器:圆盘式旋光仪,微机型旋光仪,参数全显旋光仪,恒温旋光仪,大角度旋光仪,多波长旋光仪,目视自动熔点仪,微机熔点仪,药物熔点仪,自动阿贝折射仪,恒温阿贝折射仪,阿贝折射仪,微机阿贝折射仪,光学阿贝折射仪,指针式粘度计,数字式粘度计,细菌浊度仪,散射光浊度仪,在线浊度仪,光泽度仪,分光测色仪色差仪,比较测色仪,啤酒色度仪,罗维朋比色计,光电轮廓仪,光电雾度仪,透光率雾度测定仪,气体测定仪,激光粒度分析白度计,应力仪实验室箱体:药物稳定性试验箱,药品冷藏箱,恒温恒湿箱,光照培养箱,人工气候箱,生化培养箱,霉菌培养箱,二氧化碳培养箱,厌氧培养箱,振荡培养箱,隔水式培养箱,电热恒温培养箱,培养干燥箱两用箱,电热鼓风干燥箱,真空干燥箱,远红外快速干燥箱,电热恒温干燥箱,热空气消毒箱,高温箱,胶片箱,高温恒温试验箱,胶片干燥箱,老化试验箱,盐雾腐蚀试验箱,程控箱式电阻炉,电热恒温水浴,电热恒温油浴,电热恒温水浴锅,三孔三温水槽,电热恒温水槽,低温恒温槽,电热恒温金属浴,低温循环泵,紫外光耐气候试验箱,水槽、水浴锅两用仪生化仪器:集菌仪,无菌检查过滤器,微生物限度仪,匀浆仪,无菌均质器,智能菌落计数器,三用紫外分析仪,酶标仪,洗板机,电泳槽,电泳仪,超声波细胞破碎仪,电脑自动部份收集器,间歇浸式生物反应器,冷冻干燥机,旋转混合器,自动漩涡混合器,脉动式多管漩涡混合器,驱动混合器,全自动洗瓶消毒机,数控层析冷柜,数码凝胶成像分析系统(含软件),台式紫外透射仪,细胞融合仪,制冰机,紫外交联仪电子天平衡器:电子分析天平,密度电子天平,精密扭力天平,液体比重天平,纺织天平,珠宝电子天平,质量比较仪,防水天平,静水力学天平,防爆电子天平,砝码,机械天平,计数电子天平常规实验仪器:超纯水机,离心机,旋转蒸发器,手提式,立式高压灭菌器,卧式高压灭菌器,高速分散剪切乳化机,高速分散均质机,高速分散器,万能粉碎机,中草药粉碎机,微型植物粉碎机,微型土壤粉碎机,蠕动泵,隔膜泵,防爆旋片真空泵,循环水真空泵,真空离心浓缩仪,冷阱,低温循环泵,玻璃反应釜,玻璃仪器烘干器,电动匀浆仪,数控超声波清洗器,超声波细胞粉碎机,电热蒸馏水器,除湿机,磁力搅拌器,电动搅拌,石墨消解仪光学仪器:相差显微镜,金相显微镜,体视显微镜,偏光显微镜,荧光显微镜,生物显微镜。

国外GMP对制药设备的要求

国外GMP对制药设备的要求
产的中间体或原料药调查关键仪器相对于 合格校验标准的偏差,以便确定这些偏差 的质量是否有影响。
Q7A对制药设备控制与要求
5 计算机控制系统 5.1 应当有计算机系统操作和维护的书面SOP 5.2 对计算机化系统所做的变更应当按照变 更SOP进行,并应当经过正式批准并做验证 5.3 所有变更记录都应当保存,包括对系统 的硬件、软件和任何其它关键组件的修改和升 级。这些记录应当证明该系统维持在验证过的 状态。
5.9 除计算机系统外,数据可以用第二种方式记录。
第四部分:CHN GMP对制药设备 控制与要求
第三十一条 设备的设计、选型、安装应符合 生产要求,易于清洗、消毒或灭菌,便于生 产操作和维修、保养,并能防止差错和减少 污染。
第三十二条 与药品直接接触的设备表面应光 洁、平整、易清洗或消毒、耐腐蚀, 不与 药品发生化学变化或吸附药品。设备所有的 润滑剂、冷却剂等不得对药品或容器造成污 染。
• 3.37 所使用的清洗和清洁设备应经过选择, 它们的使用不应成为一个污染源。
• 3.38 设备的安装应能够防止安装后的误操 作风险或污染。
• 3.39 生产设备不得对产品带来危害。接触 产品的设备部件与产品不得发生反应、混 容和吸附以至于达到影响产品质量的程度, 避免带来任何危害。
Equipment 设备
• Equipment 设备
Equipment 设备
• 3.34 生产设备的设计、位置和维修维护应适 合于其用途。
• 3.35 维修和维护操作不得对产品质量带来任 何风险。
• 3.36 生产设备的设计应易于做到彻底的清洁。 其清洁应按照详细的书面程序进行,生产设 备只能储存于干净和干燥的环境中。
Equipment 设备
• 3.2,如果必须使用脱落纤维的过滤器,那么必须另 用0.22微米的不脱落纤维的滤膜终端过滤. (如实 际生产条件限制,可用0.45微米),以降低注射剂 内微粒数量;

中国GMP2010中英文对照ISPE翻译版

中国GMP2010中英文对照ISPE翻译版

)》(2010年修订年修订)《药品生产质量管理规范药品生产质量管理规范(《Good Manufacturing Practice (2010 revision) 》Reviewed by ISPEMa Yiling, Zhang Jianye, Yang YalanInitial Translation from NNE Pharmaplan目录Table of Contents第一章 总则 (5)第一章Chapter1 General Provisions (5)第二章质量管理 (6)Chapter 2 Quality management (6).第一节原 则 (6).Section 1 Principle (6).第二节 质量保证 (6).Section 2 Quality Assurance (6).第三节 质量控制 (8).Section 3 Quality Control (8)第三章 机构与人员 (10)Chapter 3 Organization and personnel (10).第一节 原 则 (10).Section 1 principle (10).第二节 关键人员 (10).Section 2 Key Personnel (10).第三节 培 训 (14).Section 3 training (14)第四章 厂房与设施 (16)Chapter 4 Premises and facilities (16).第一节 原 则 (16).Section 1 principle (16).第二节 生产区 (17).Section 2 Production Area (17).第三节 仓储区 (20).Section 3 Storage Areas (20).第四节 质量控制区 (21).Section 4 Quality Control Areas (21).第五节 辅助区 (21).Section 5 Ancillary Areas (21)第五章 设 备 (22)Chapter 5 Equipment (22).第一节 原 则 (22).Section 1 principle (22).第二节 设计和安装 (22).Section 2 Design and Installation (22).第三节 维护和维修 (23).Section 3 Maintenance and Repair (23).第四节 使用和清洁 (23).Section 4 Usage and Clean (23).第五节 校 准 (24).Section 5 Calibration (24).第六节 制药用水 (25).Section 6 Water for Pharmaceutical Process (25)第六章物料与产品 (26)Chapter 6 Material and products (26).第一节原 则 (26).Section 1 Principle (26).第二节 原辅料 (27).Section 2 Raw materials and Excipients (27).第三节中间产品和待包装产品 (28).Section 3 Intermediate and Bulk products (28).第四节 包装材料 (29).Section 4 Packaging material (29).第五节成 品 (30).Section 5 Finished products (30).第六节特殊管理的物料和产品 (30).Section 6 Particular management for materials and products (30).第七节其 他 (30).Section 7 others (30)第七章确认与验证 (32)Chapter 7 Qualification and validation (32)第八章文件管理 (34)Chapter 8 Documentation (34).第一节原 则 (34).Section 1 Principle (34).第二节质量标准 (36).Section 2 Specification (36).第三节工艺规程 (37).Section 3 Process procedures (37).第四节批生产记录 (39).Section 4 Batch Production Records (39).第五节批包装记录 (40).Section 5 Batch Packaging Records (40).第六节操作规程和记录 (41).Section 6 Operation Procedures and Records (41)第九章 生产管理 (42)Chapter 9 Production Section (42).第一节 原 则 (42).Section 1 Principle (42).第二节防止生产过程中的污染和交叉污染 (44).Section 2 Prevention of Contamination and cross contamination (44).第三节生产操作 (45).Section 3 Production Operations (45).第四节包装操作 (45).Section 4 Packaging Operations (45)第十章质量控制与质量保证 (47)Chapter 10Quality Control and Quality Assurance (47).第一节质量控制实验室管理 (47).Section 1 Good Quality Control Laboratory Practice (47).第二节物料和产品放行 (55).Section 2 Release for Materials and Products (55).第三节持续稳定性考察 (56).Section 3 On-going stability programme (56).第四节变更控制 (58).Section 4 Change control (58).第五节偏差处理 (59).Section 5 Deviation Treatment (59).第六节纠正措施和预防措施 (60).Section 6 Corrective action and preventive action (CAPA) (60).第七节供应商的评估和批准 (61).Section 7 Audit and approal of suppliers (61).第八节产品质量回顾分析 (63).Section 8 Product Quality Review (63).第九节 投诉与不良反应报告 (65).Section 9 Complaints and Adverse Reactions Report (65)第十一章 委托生产与委托检验 (66)Chapter 11 Contract manufacture and analysis (66).第一节原 则 (66).Section 1 Principle (66).第二节委托方 (66).Section 2 The Contract Giver (66).第三节受托方 (66).Section 3 The Contract Acceptor (66).第四节合 同 (67).Section 4 The Contract (67)第十二章 产品发运与召回 (68)Chapter 12 Product distribution and recall (68).第一节原 则 (68).Section 1 Principle (68).第二节发 运 (68).Section 2 Distribution (68).第三节召 回 (68).Section 3 Recalls (68)第十三章 自 检 (69)Chapter 13Self inspection (69).第一节 原 则 (69).Section 1Principle (69).第二节 自 检 (69).Section 2Self inspection (69)第十四章 附 则 (70)Chapter 14 Glossary (70)Note:Highlight (Yellow) is the differences between EU GMP and SFDA GMP (new version). The first difference is that Chinese GMP combines all the requirements for both API and medicinal products, while EU GMP divides them to two parts.No highlight: is the similarity between the two guidelines.第一章 总则Chapter1 General Provisions第一条为规范药品生产质量管理,根据《中华人民共和国药品管理法》、《中华人民共和国药品管理法实施条例》,制定本规范。

医疗器械GMP认证要求解读

医疗器械GMP认证要求解读

医疗器械GMP认证要求解读医疗器械是我们日常生活中不可或缺的一部分,而GMP(Good Manufacturing Practice)认证对于医疗器械企业来说,具有重要的意义。

本文将对医疗器械GMP认证的要求进行解读,以帮助读者更好地了解和应用相关知识。

一、GMP认证背景介绍GMP认证是一项全球性的质量管理体系,旨在确保医疗器械的生产和销售过程中遵循一系列标准和规定,以确保产品的质量、安全和有效性,保障人民群众的生命健康。

通过GMP认证,企业可以提高生产管理水平,降低产品质量风险,提升企业竞争力,获取市场认可。

二、GMP认证的主要要求1. 设施和设备要求医疗器械企业在进行生产、贮存和分销过程中,必须具备符合卫生要求的建筑设施和生产设备。

设施和设备应当易于清洗和维护,能够控制环境条件和防止交叉污染。

2. 员工要求医疗器械企业应保证员工具备相关专业知识和技能,并进行定期培训,以确保他们能够正确理解和执行相关操作规程。

员工应遵守卫生、卫生和安全政策,并负责监督产品质量。

3. 质量管理体系要求医疗器械企业应建立一套完整的质量管理体系,包括质量控制、质量保证和质量改进等环节。

企业应制定并执行标准化的操作规程,并保留相应的记录,以便追溯产品的生产过程和质量管理。

4. 原材料和产品要求医疗器械企业应对原材料进行严格检验,确保其符合相关质量要求,并建立合理的物料管理制度。

生产过程中,企业应采取适当的控制措施,确保产品的质量稳定性和一致性。

5. 清洁和卫生要求医疗器械企业应制定并实施适当的清洁和卫生措施,以确保生产环境的干净、卫生。

这包括有关人员卫生、设备清洁、废物处理等各个方面。

6. 记录和文件要求医疗器械企业应建立并保留适当的记录和文件,如生产记录、质量记录、培训记录等,以提供给监管机构进行审查。

这些记录和文件应完整、准确地反映企业的生产和质量管理情况。

三、GMP认证的优势和意义1. 提升产品质量和安全性。

GMP认证要求企业建立完善的质量管理体系,从原材料到产品的每一个环节都有相应的规范和要求,保证产品的质量和安全性。

新版GMP认证设备篇解析

新版GMP认证设备篇解析

新版GMP认证设备篇解析第一篇:新版GMP认证设备篇解析药品生产质量管理规范(2010年修订)检查指南第五章设备检查核心药品GMP的目的及基本要求是最大限度地降低药品生产过程中污染、交叉污染以及混淆、差错等风险,确保持续稳定地生产出符合预定用途和注册要求的药品。

设备在设计、安装、维护、使用和清洁的过程中也应基于以上原则来进行管理。

企业应建立完善的设备管理系统,根据药品生产不同产品剂型的要求和规模,选择和使用合理的生产设备,配备必要的工艺控制机设备的清洗、消毒、灭菌等功能,并通过完整的验证流程保证设备的性能满足预期要求。

在使用中通过必要的校准、清洗和维护手段,保证设备的有效运行,并通过生产过程控制、预防维修、校验、再验证等方式保持持续验证状态。

设备的清洁是防止污染与交叉污染的一个重要手段,应强调清洁方法的有效性和可重现性。

【检查条款及要点】第一节原则第七十一条设备的设计、选型、安装、改造和维护必须符合预定用途,应当尽可能降低产生污染、交叉污染、混淆和差错的风险,便于操作、清洁、维护,以及必要时进行的消毒或灭菌。

条款解读1、应有熟悉产品工艺人员和设备使用人员起草一份综合各方意见的用户需求文件。

设备项目负责人员依据用户需求文件进行设备调研、选型,并转化成符合相关设备技术语言的技术要求,其中对关键技术指标做详细、明确的描述,并用于设备设计、制造、安装、调试、验收的合同技术文件。

2、在相关设备设计、选型和安装要求的基础上,根据基本原则重新进行组织,系统阐述设备管理的目的。

3、设备的选型和设计应当满足生产规模及生产工艺的要求;用于制剂生产的配料、混合、灭菌的主要生产设备和用于精制、干燥、包装的设备,其容量应当与生产的批量向适应。

检查要点1、设备保障应制定设备的设计、选型、安装、改造和维护等方面的管理规程,同时包括工艺设备和公用系统。

2、企业设备的设计、选型,应当根据自身条件(选址面积、厂房结构、生产能力、设备、硬件设施系统等)、环境、用途、使用目的、标准要求等提出用户需求(USR)。

实验室干燥器 en标准

实验室干燥器 en标准

实验室干燥器 en标准
其中,制造方面的要求包括干燥器的材料、设计、制造工艺和产品质量等标准;安装方面的要求包括干燥器的安装位置、支撑结构、管路连接和电气接线等标准;使用方面的要求包括干燥器的使用范围、操作方法、安全性指标和环境要求等标准;维护方面的要求包括干燥器的日常保养、维修和更换零部件等标准;测试方面的要求包括对干燥器进行性能测试、安全测试和环境测试等标准。

实验室干燥器en标准对干燥器的制造商、安装商和使用者都有
着重要的指导意义,可以保障干燥器的质量和安全性,提高实验室实验的准确性和可靠性。

- 1 -。

(完整版)欧盟GMP附录

(完整版)欧盟GMP附录

(完整版)欧盟GMP附录欧洲共同体:European Communities (EC)。

欧洲联盟:European Union (EU),简称欧盟。

⼈⽤药品注册技术标准国际协调会:ICH欧盟GMP附录1⽆菌药品的⽣产注:冻⼲瓶轧盖的条款⾃2010年3⽉1⽇开始实施。

原则为降低微⽣物、微粒和热原污染的风险,⽆菌药品的⽣产应有各种特殊要求。

这在很⼤程度上取决于⽣产⼈员的技能、所接受的培训及其⼯作态度。

质量保证极为重要,⽆菌药品的⽣产必须严格按照精⼼制订并经验证的⽅法和规程进⾏。

产品的⽆菌或其它质量特性绝不能仅依赖于任何形式的最终操作或成品检验。

注:本指南没有对微粒、浮游菌和表⾯微⽣物等测试⽅法详细进⾏阐述,可参阅欧洲标准或国际标准(CEN/ISO)及药典资料。

总则1.⽆菌药品的⽣产必须在洁净区内进⾏,⼈员和(或)设备以及物料必须通过缓冲进⼊洁净区。

洁净区应当保持适当的洁净度,洁净区的送风须经具有⼀定过滤效率过滤器的过滤。

2.原料配制、产品加⼯和灌装等不同操作必须在洁净去内彼此分开的单独区域内进⾏。

⽣产⼯艺可分为两类:⼀类是最终灭菌⼯艺;第⼆类是部分或全部⼯序为⽆菌操作的⼯艺。

3.应按所需环境的特点确定⽆菌产品的洁净级别。

每⼀步⽣产操作都应达到适当的动态洁净度,以尽可能降低产品(或原料)被微粒或微⽣物污染。

洁净区的设计必须符合相应的“静态”标准,以达到“动态”的洁净要求。

“静态”是指安装已经完成并已运⾏,但没有操作⼈员在场的状态。

“动态”是指⽣产设施按预定的⼯艺模式运⾏并有规定数量的操作⼈员进⾏现场操作的状态。

应确定每⼀洁净室或每组洁净间的“动态”及“静态”标准。

⽆菌药品⽣产所需的洁净区⼀般可分为4个级别:A级:⾼风险操作区,如:灌装区,放置胶塞桶、敞⼝安瓿瓶、敞⼝西林瓶的区域及⽆菌装配/连接操作的区域。

通常⽤单向流操作台/罩来维护该区的环境状态。

单向流系统在其⼯作区域必须均匀送风,风速为0.36-0.54m/s(指导值)。

gmp 附录一隔离器 背景环境 要求

gmp 附录一隔离器 背景环境 要求

gmp 附录一隔离器背景环境要求以GMP附录一隔离器背景环境为标题的文章随着医药行业的不断发展和进步,对于药品的生产质量和安全性要求也越来越高。

药品的生产过程中,存在着可能会受到外界环境污染的风险,因此需要在生产过程中采取一系列的措施来确保药品的质量和安全性。

GMP(Good Manufacturing Practice,良好生产规范)作为一种国际上公认的药品生产质量管理体系,规定了药品生产过程中的各项要求和标准。

GMP附录一隔离器就是其中之一。

GMP附录一隔离器是一种用于生产过程中隔离有害物质和保护操作人员安全的设备。

隔离器的主要作用是将操作人员与药品或其他有害物质隔离开来,防止操作人员接触到有害物质,同时也防止有害物质对外界环境的污染。

在药品生产过程中,一些药物可能具有较高的毒性或易感染性,如果操作人员接触到这些药物,可能会对其健康产生严重的危害。

因此,必须采取一些措施来保护操作人员的安全。

GMP附录一隔离器就是一种非常有效的措施之一。

GMP附录一隔离器主要由两部分组成:一个是隔离箱体,另一个是操作手套箱。

隔离箱体是一个密封的空间,用于将操作人员与药品隔离开来。

操作手套箱是一个装有手套的密封箱体,操作人员可以通过手套进行操作,而不会直接接触到药品。

隔离器的工作原理是通过负压控制来实现的。

在隔离箱体内部,通过空气流动的方式,将箱体内部保持在一个较低的压力状态,这样就可以防止有害物质逸出到箱体外部。

同时,通过过滤器对进入隔离器的空气进行过滤,确保空气中不含有有害物质。

在使用GMP附录一隔离器的过程中,需要严格遵守操作规程和操作要求。

操作人员必须进行专门的培训,熟悉隔离器的使用方法和操作流程。

在操作过程中,需要佩戴相应的个人防护装备,如手套、口罩和防护服等。

同时,需要对隔离器进行定期的维护和清洁,确保其正常工作和安全使用。

GMP附录一隔离器的使用不仅能够保护操作人员的安全,还能够保证药品的质量和安全性。

欧盟GMP指南 第5章生产(中英文20150123)

欧盟GMP指南 第5章生产(中英文20150123)

EU GMP 第1部分第5章生产——增加基因毒性的评估生效时限2015-02-25 11:50:00(粉色字为2015年1月23日新增内容,红字斜体为2014年8月13日修订内容)Ref. Ares(2015)283689 - 23/01/2015 EUROPEAN COMMISSIONHEALTH AND CONSUMERS DIRECTORATE-GENERALPublic Health and Risk AssessmentMedicinal products – quality, safety and efficacyBrussels, 13 August 2014Ares(2014)2674301EudraLexThe Rules Governing Medicinal Products in the European UnionVolume 4EU Guidelines forGood Manufacturing Practice forMedicinal Products for Human and Veterinary UsePart 1Chapter 5: Production人兽药EU GMP指南第1部分第5章:生产Legal basis for publishing the detailed guidelines: Article 47 of Directive 2001/83/EC on the Community code relating to medicinal products for human use and Article 51 of Directive 2001/82/EC on the Community code relating to veterinary medicinal products. This document provides guidance for the interpretation of the principles and guidelines of good manufacturing practice (GMP) for medicinal products as laid down in Directive 2003/94/EC for medicinal products for human use and Directive 91/412/EEC for veterinary use.Status of the document: Revision [a]Reasons for changes: Changes have been made to sections 17 to 20 to improve the guidance on prevention of cross-contamination and to refer to toxicological assessment guidance. Changes were also introduced in sections 26 to 28 on the qualification of suppliers in order to reflect the legal obligation of manufacturing authorisation holders to ensure that active substances are produced in accordance with GMP. The changes include supply chain traceability. Section (33) is inserted to clarify and harmonise expectations of manufacturers regarding the testing of starting materials while section (68) introduces guidance on notification of restrictions in supply.变更理由:对17-20条进行变更,以改进指南中防止交叉污染的部分,及引用毒理学评估指南。

  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

B10ENGMP+ Feed Safety Assurance schemeLaboratory testingGMP+ B10Version: January 1st , 2012© GMP+ International B.V.All rights reserved. The information in this publica-tion may be consulted on the screen, downloaded and printed as long as this is done for your own, non-commercial use. For other desired uses, prior written permission should be obtained from the GMP+ International B.V.History of the documentINDEX1INTRODUCTION 51.1G ENERAL51.2S TRUCTURE OF THE GMP+F EED S AFETY A SSURANCE SCHEME51.3S COPE AND APPLICATION OF THIS STANDARD61.4T HE STRUCTURE OF THIS STANDARD71.5E XCLUSION OF REQUIREMENTS7 2NORMATIVE REFERENCES 82.1GMP+D OCUMENTS8 3ORGANISATION AND QUALITY POLICY 93.1Q UALITY SYSTEM93.2O RGANISATIONAL DIAGRAM93.3M ANAGEMENT OF THE QUALITY SYSTEM9 4DOCUMENTATION 104.1R ECORDS104.2M ANUAL104.3D ATE AND AUTHORISATION10 5ACCOMMODATION 115.1E NVIRONMENT115.2A CCESS REGULATION115.3F ACILITIES11 6PERSONNEL 12 7EQUIPMENT 137.1I TEMS TO BE RECORDED137.2L OGBOOK13 8SAMPLES, STANDARD, REFERENCE AND AUXILIARY MATERIAL 148.1S PECIFICATIONS148.2C HECK148.3L IST OF AUTHORISED SUPPLIERS148.4I DENTIFICATION148.5P RECAUTIONARY MEASURES148.6I NSTRUCTIONS149INSTRUCTIONS 159.1I NSTRUCTIONS AND DESCRIPTION159.2F AMILIARITY WITH THE INSTRUCTIONS15 10REGISTRATION, REPORTING AND ARCHIVING 1610.1R EGISTRATION1610.2R EPORTING1610.3A RCHIVING1610.4P ROTECTION DATA16 11QUALITY CONTROL PLAN AND INTERNAL AUDITS 1711.1Q UALITY CONTROL PLAN1711.2R ECORDS1711.3F REQUENCY1711.4R EPORTING17 12PEER GROUP TESTING 1812.1P ARTICIPATION1812.2A DMINISTRATION1812.3I NSTIGATION OF TESTING18 13CONTRACTING OUT TO OTHER LABORATORIES 19 14COMPLAINTS PROCEDURE 19 15QUALITY CONTROL OF THE TESTING AND CALIBRATION RESULTS 20 16SEROLOGICAL CLASSIFICATION FOR SALMONELLA 21 17COMMENTARY 221 Introduction1.1 GeneralThe GMP+ Feed Safety Assurance Scheme (GMP+ FSA scheme) was initiated and developed in 1992 by the Dutch feed industry in response to various more or less serious incidents involving contamination in feed materials. Although it started as a national scheme, it has developed to become an international scheme that is managed by GMP+ International in collaboration with various international stake-holders.The GMP+ FSA scheme is a complete scheme for the assurance of feed safety in all the links of the feed chain. Demonstrable assurance of feed safety is a 'license to sell’ in many countries and markets and participation in the GMP+ FSA scheme can facilitate this excellently.The basic principle of the GMP+ FSA scheme is that the feed chain is part of the food production chain. Proper quality assurance of feed safety throughout the feed chain has a high priority. It is important that companies take their responsibilities in this respect by responding in a proper and convincing way to the need for safe feed materials in the food production chain.Based on needs in practice, multiple components have been integrated into the GMP+ FSA scheme, such as requirements for the quality management system (ISO 9001), HACCP, product standards, traceability, monitoring, prerequisites pro-grammes, chain approach and the Early Warning System.Together with the GMP+ partners, GMP+ International transparently sets clear re-quirements so that feed safety is guaranteed and certification bodies are able to carry out GMP+ certification independently.GMP+ International supports the GMP+ participants with useful and practical infor-mation by way of its various databases, newsletters, Q&A lists and seminars.1.2 Structure of the GMP+ Feed Safety Assurance schemeThe documents within the GMP+ FSA scheme are subdivided into a number of series. The next page shows a schematic representation of the contents of the GMP+ FSA scheme:All these documents are available via the website of GMP+ International().This document is referred to as GMP+ B10 Laboratory testing and is part of the GMP+ FSA scheme.1.3 Scope and application of this standardAnalysing on samples of feed additives, feed materials, premixes and feed in the context of the GMP+ FSA scheme should take place in such a way the reliability of the results produced is controlled and assured. This standard specifies the re-quirements for a quality assurance system in which a laboratory can ensure that the results of the analyses sufficiently reliable, and is intended for (internal com-pany) laboratories which carry out analyses within the framework of the GMP+ FSA scheme.A laboratory may participate for its analysis activities in the GMP+ FSA scheme. To do this it should establish a quality assurance system which complies with the re-quirements of this standard. The applicant must manage and ensure compliance with critical points such as receipt, storage and treatment of samples, analysis, reg-istration, reporting and archiving.Certification will take place according to the type of subject as well as the analytical method and matrix employed, which are also to be stated on the certificate. A sub-ject is something which can be analysed by means of an analytical method.In this standard the words ‘laboratory’ and ‘applicant’ are used diversely. Both words refer to the organisation which has implemented the quality system. Thew ord ‘laboratory’ sometimes refers in addition to the building or area where the analysis activities take place.The requirements of this standard apply to organisations, irrespective of their type or size, which carry out activities which are covered within the scope of this stan-dard.It is not important whether a company carries out these activities on its own ac-count or as a (sub) contractor (‘service provider’).If a participant carries out activities with feeds which are outside the scope of this standard then it may be necessary to apply another GMP+ standard instead of, or in addition to, this standard.For exact details is referred to GMP+ C1 Approval Requirements and Procedure for Certification Bodies, Appendix 1The participant remains responsible at all times for the safety of the feeds and ac-tivities associated with them, as well as for checking on compliance with the re-quirements. This must be done by the participant himself. By complying with the requirements of this standard and by being certified accordingly, the participant can demonstrate the safety and quality of his services or feeds to third parties. Irrespective of the obligations arising from this standard, the participant will only place on the market or offer services regarding feeds which are safe for animals and (indirectly) safe for the consumers of the animal products.1.4 The structure of this standardThis standard has its own structure. This standard is easy to combine with other standards.GMP+ Appendices (GMP+ BAxx), to which there are also references, are separate GMP+ documents within the B segment. If there is a reference in this standard then it applies within the framework of this standard. See also Chapter 2.1.5 Exclusion of requirementsIt is possible that certain requirements do not apply to a participant. A participant may exclude these requirements. Exclusions must, however, be justified and re-corded. The exclusions may in any event not lead to the participant supplying feeds or offering services which do not comply with feed safety as defined in the GMP+ FSA scheme.No requirements may be excluded because the participant finds them to be not relevant such as because customers do not ask for them or because compliance with these requirements is not a legal obligation or because the company is small.2 Normative references2.1 GMP+ DocumentsIn addition to the requirements listed in this GMP+ standard, the participant must also comply with the requirements included in the GMP+ Appendices (GMP+ BA xx) to which reference is made in this standard.The participant must also comply with the relevant requirements as recorded in the GMP+ A-documents.These documents can be found on the GMP+ International’s website()3 Organisation and quality policy3.1 Quality systemThe applicant must have a quality system in place which includes the organisation and documentation of responsibilities, authorisations, procedures, processes and the provisions made in relation to the management and guaranteeing of the reliabil-ity of the analytical results. Responsibility for the proper structure and operation of the quality system rests with the directors of the business.3.2 Organisational diagramAn organisational chart should be provided to show how the laboratory fits into the organisation of the business. The applicant and its personnel should have a posi-tion independent of any activities related to the production and trading of additives, feed materials, premixes and feed carried on elsewhere in the business. The man-ager of the quality system must have direct access to the company directors. Inter-nal inspections (internal audits) should be carried out by a person who is suitably independent of the activities to be audited. The auditor must also possess ade-quate knowledge of the activity to be audited.3.3 Management of the quality systemThere must be a procedure in place to govern authorisations in connection with amendments, modifications, additions or reviews of the quality system. A manager will be appointed within the business to be responsible for the currency, manage-ment and distribution of the manual.4 Documentation4.1 RecordsIn recording events it is necessary; both for the proper functioning of the laboratory and for the purpose of demonstrability with respect to any assessor, that all the matters indicated by the participant in the quality system are recorded or clearly observable. Everyone in the laboratory involved with any element of the quality system must be aware of this and actively work towards its achievement.It will be clear that mere paper recording will not suffice. It must also be demonstra-ble from the people doing the work, from the equipment used and the working ar-rangements, etc., that the relevant elements of this standard function in practice.4.2 ManualOne of the requirements for the proper functioning of the quality system is that it should be set down in a manual. Only in this way does the cohesion among the critical points and the quality of the results of analysis become transparent by the applicant.Putting the quality system into writing will create the manual, which provides an ongoing reference source for the implementation and maintenance of the quality system. The manual must demonstrably be kept up to date.4.3 Date and authorisationThe documented instructions and procedures must be dated and authorised by a person nominated by the directors of the business.5 Accommodation5.1 EnvironmentThe environment/location where the analytical procedures are carried out must not affect the accuracy and precision of the analytical results.5.2 Access regulationThere is to be a procedure controlling access to the laboratory, approved by the Directors, which will ensure that the integrity of the results is not affected.The following matters must be dealt with, as a minimum:a. sample storage is secure against unauthorised access;b. data is secureThe laboratory must be accessible only to laboratory personnel. Other persons may only enter the room in the presence of laboratory personnel.5.3 FacilitiesProvision should be made for:a. the reception of sample material;b. the storage of samples;c. the cleaning of glasswork and other equipment;d. the preparation and storage chemical reagents and similar;e. the carrying out of the tests, including the preparation of samples;These provisions should be appropriate given the aims of the quality system.6 PersonnelThe laboratory personnel are of crucial importance in managing and guaranteeing the quality of the analytical results. The personnel must therefore have the knowl-edge and capabilities required for their allotted tasks in this context.In order to achieve this it is necessary in any event that:a. their tasks, responsibilities and authority are made clear to them, in writing;b. there is an established procedure in place to ensure that all personnel involvedare aware of the necessary instructions and standards. They should be kept in-formed at least in writing, on a regular basis, and certainly in the event of es-sential modifications. This also applies to temporary personnel;c. personnel received adequate initial and follow-up training. This should be ap-parent from the personal files and/or a training programme.7 Equipment7.1 Items to be recordedThe following matters should be recorded with regard to the equipment and tools provided which might affect the outcome of the analytical work:a. an inventory of the equipment available, stating the method of identificationemployed;b. a maintenance system, stating the frequency and nature of the maintenancework to be carried out, including adjustment, calibration and validation, and stating who is authorised to carry out such activities. The calibration should be able to be derived from primary standards;c. the suitability of quality inspection equipment for its particular purposes: in theevent of faults in equipment: the measures that are and must be taken in rela-tion to the use of the equipment, as well as the assessment of the validity of in-spection results obtained previously.7.2 LogbookThe maintenance activities, repaired faults, calibrations, adjustments and valida-tions as specified under section 6.1 should be recorded in a logbook. Malfunctioning equipment must be marked as such (“quarantined”).8 Samples, standard, reference and auxiliary material8.1 SpecificationsSpecifications should be available for the required quality of standard and reference materials and auxiliary material (chemicals). These should be recorded.8.2 CheckStandard, reference and auxiliary materials should be checked on delivery to estab-lish that what was ordered was in fact received.8.3 List of authorised suppliersThere should be information available on the quality and reliability of suppliers of standard, reference and auxiliary materials. A list of authorised suppliers should be drawn up on the basis of this information.Checks should be carried out on the usability of critical standard, reference and auxiliary materials. Frequency of checks is dependent on the extent to which the standard, reference and auxiliary materials are critical for the outcome of the analy-ses. A procedure must be laid down for this.8.4 IdentificationStandard, reference and auxiliary materials must be uniquely identified and pro-vided with an expiry date and storage instructions where these are important for quality.8.5 Precautionary measuresPrecautionary measures should be in place at all stages of storage, sample prepa-ration and processing and investigation, in order to avoid any possible unfavourable effects on the results of analysis. Instructions should be available for these pur-poses, and these should be kept under review.8.6 InstructionsInstructions should be available covering receipt, storage life and destruction of samples and standard, reference and auxiliary materials.9 Instructions9.1 Instructions and descriptionInstructions should be available to cover:a. the operation, maintenance, calibration and adjustment of equipmentb. the handling of samplesc. the realization of the testing (the analysis), including the control provisions tobe carried out. A control sample should be included in each series, the fre-quency is matched to single or duplicate control tests), the way in which the re-sults of the control provisions are interpreted and the records and reports of the results. The responsibility for acceptance and reporting of analytical resultsshould be clearly set out.The under GMP+ B10 Laboratory Testing executed analyses should be validated. Depending on the type of analysis, at least the following performance features should be determinedAny test instructions should include at least a description of the following:a. equipment;b. reagents;c. other auxiliary materials, andd. acceptance criteria for the analytical results obtained.It should also be stated whether and when the determination should be carried out on a single or duplicated basis. In the case of single analysis there should be suffi-cient guarantees built in to ensure the quality of the analytical result, for example through the inclusion of additional control analyses.9.2 Familiarity with the instructionsThe current instructions must be known to the personnel involved. Work must be carried out in accordance with the (current version of the) instructions.10 Registration, reporting and archiving10.1 RegistrationThe following data should be unambiguously recorded:a. the identity of the sample (type, source, sample number);b. date of receipt of sample;c. testing methodology adopted;d. results of analysis; in the case of microbiological analysis, stating the quantityused in the test;e. results of confirmatory tests (if applicable);f. results of control analyses Determination and evaluation to be in accordancewith the methodology described under section 11.2 and 11.3;g. any irregularities detected;h. names of those carrying out the investigation and authenticating the results. The records should be preserved so as to prevent their unintended loss, and any amendments must be verifiable.10.2 ReportingResults may be reported only by authorised persons on behalf of the participant. The following items must be reported in the case of each sample:a. identity of the sample;b. sample number;c. any batch or reference number (provided by the client);d. date of receipt of the sample;e. final result or results;f. any remarks;g. report date by the person responsible for drawing up the report;h. authorisation by the person responsible for the report;i. person for whom the report is intended;j. the testing method used including the version number (possibly reclaimable).10.3 ArchivingAll data which might be significant in reconstructing how a particular result was achieved must be retained. The following items should be archived (possibly in electronic form) for at least 2 years:a. the records mentioned in section 9.1;b. a copy of each of the reports mentioned under section 9.2;c. the equipment log-books mentioned under section 6.2;d. results of internal inspections and checks;e. replaced documents (manual, procedures, instructions etc).10.4 Protection dataThere should be adequate security to prevent unauthorised access to and amend-ment of information.11 Quality control plan and internal audits11.1 Quality control planThe applicant is to draw up a quality control plan to include all relevant checking recorded in the quality system. The results are to be compared to the company’s internal standards.The quality control plan is to include at least the following elements:a. identification of critical points, in a logical and systematic sequence;b. the required checks, and their frequency;c. persons responsible for carrying out checks.11.2 RecordsThe results of the quality control plan are to be recorded on inspection forms devel-oped for the purpose, stating the following as a minimum:a. items to be inspected, and the results;b. the section of the laboratory involved;c. inspection date;d. name of inspector;e. actions taken.The applicant should instigate an investigation into the cause of any irregularities, and to rectify these. The action taken, the rationale and the results should be re-corded.11.3 FrequencyInternal audits should be carried out at least once per year.11.4 ReportingThe results, their evaluation and the actions taken should be reported to the direc-tors of the laboratory. The (final) responsibility for taking action in the case of ir-regularities rests with the directors of the business.12 Peer group testing12.1 ParticipationThe applicant should take part in inter-laboratory tests (peer group tests) dealing with the analytical methods used by the participant and based where possible on proficiency testing.12.2 AdministrationFor each operation, the laboratory’s results, as compared with the mean calculated from the relevant peer group test are to be retained and archived for a minimum of 3 years. The results should show the deviation from the mean, expressed as multi-ples of the spread (“s”) calculated for the peer group test in question, and pr e-sented as a summary or graph.12.3 Instigation of testingThe laboratory must instigate an investigation into the cause of deviations and rec-tify them, where the following occurs:a. one deviation of more than 3 x sb. two consecutive times with a deviation of more than 2 x s on the same side ofthe averagec. or eleven four consecutive results on the same side of the average.This action taken, the rationale and the results should be recorded.13 Contracting out to other laboratoriesAnalytical work may only be contracted out to laboratories which are certified for the work in question under this or some other equivalent standard.Operations which are contracted out are not eligible for certification.Where analytical work is contracted out to third parties, the report to the client must make it clear that the analysis was not carried out in-house, but rather contracted out.14 Complaints procedureThe participant should have a system in place for the recording and handling of complaints.15 Quality control of the testing and calibration resultsThe laboratory must have procedures in place for quality control to monitor the va-lidity of the analyses and calibrations carried out.The details must be recorded in such a way that trends are noticed and, where practically possible, statistical methods can be used to assess the results. This monitoring should be evaluated periodically and modified where applicable. During this periodic evaluation the analysis methods used should also be evalu-ated. A check should be carried out on whether use is made of the most current version of a method and whether there is a need to (re)validate the method.16 Serological classification for salmonellaIf a laboratory carries out serological classification for Salmonella within the framework of its GMP+ B10 Laboratory Testing certification then it should comply with the following additional requirements:a. The laboratory must be able to classify feed materials for at least the followingserological types:1 Enteritidis;2 Typhimuirium;3 Infantis;4 Virchow;5 Hadar;6 Java;7 Agona;b. The laboratory is prepared and able to receive and further analyse the isolatesfrom laboratories which do not carry out serological classifications.c. Analyses will be carried out in accordance with the Kauffmann White antigenescheme .Table 1: Antigens scheme for Salmonella according to the Kauffman White scheme (Source: Bergey’s manual of Determinative Bacteriology)d. If it is a type which can not be classified by the laboratory then the samplemust still be fully classified by the RIVM.e. The laboratory is obliged ot participate in the training courses organised by theRIVM for the serological classification of Salmonella.f. The laboratory is obliged (where possible) to participate in ring tests for sero-logical classification. If the laboratory books a correct result in at least 80% of these tests then it is released from the obligation specified in 7.g. The laboratory is obliged to send each year a minimum of 30 isolates to theRIVM for serological classification (duplicate testing). A minimum of 80% of the serological classifications must have a correct result. The results of the analy-ses will then be checked or confirmed.17 CommentaryA company’s own internal monitoring (under a quality control plan) has an impo r-tant place in the various GMP+ FSA standards. Such monitoring will in part be car-ried out by means of laboratory testing. The quality of such laboratory testing is therefore an essential element of quality control in the animal feed sector.This standard for laboratories has been drawn up in the interests of ensuring the quality level of these laboratory tests.The standard consists in broad terms of the following three elements:a. minimum requirements on the laboratory’s quality system, derived from EN17025;b. application of officially recognised methods (or methods providing equivalentperformance) thereby ensuring uniformity;c. participation in inter-laboratory peer-group testing, on the basis of proficiency. Certification under this GMP+ FSA standard may be combined with certification under ISO 17025.。

相关文档
最新文档